These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1598 related articles for article (PubMed ID: 31884204)
21. Emerging pathogenic links between microbiota and the gut-lung axis. Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885 [TBL] [Abstract][Full Text] [Related]
22. The possible mechanisms of the human microbiome in allergic diseases. Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907 [TBL] [Abstract][Full Text] [Related]
23. Broad-spectrum antibiotics associated gut microbiome disturbance impairs T cell immunity and promotes lung cancer metastasis: a retrospective study. Xu K; Cai J; Xing J; Li X; Wu B; Zhu Z; Zhang Z BMC Cancer; 2022 Nov; 22(1):1182. PubMed ID: 36384523 [TBL] [Abstract][Full Text] [Related]
24. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Stecher B Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088 [TBL] [Abstract][Full Text] [Related]
25. [Lung and gut microbiota and their interaction with the carcinogenesis and development of lung cancer: a review]. Zhang Y; Zhang Y; Si H Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3789-3800. PubMed ID: 34841784 [TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of alcohol induced gut dysbiosis and the resulting behavioral impact. Qamar N; Castano D; Patt C; Chu T; Cottrell J; Chang SL Behav Brain Res; 2019 Dec; 376():112196. PubMed ID: 31476330 [TBL] [Abstract][Full Text] [Related]
27. The association between gut butyrate-producing bacteria and non-small-cell lung cancer. Gui Q; Li H; Wang A; Zhao X; Tan Z; Chen L; Xu K; Xiao C J Clin Lab Anal; 2020 Aug; 34(8):e23318. PubMed ID: 32227387 [TBL] [Abstract][Full Text] [Related]
28. The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy. Liu X; Cheng Y; Zang D; Zhang M; Li X; Liu D; Gao B; Zhou H; Sun J; Han X; Lin M; Chen J Front Oncol; 2021; 11():720842. PubMed ID: 34490119 [TBL] [Abstract][Full Text] [Related]
29. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors. Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247 [TBL] [Abstract][Full Text] [Related]
30. Gut Microbiota and Lung Injury. Tan JY; Tang YC; Huang J Adv Exp Med Biol; 2020; 1238():55-72. PubMed ID: 32323180 [TBL] [Abstract][Full Text] [Related]
31. [A Study of Biomarkers in Immuno-Oncology - Correlation between Gut Microbiome Composition and the Effects of Immune Checkpoint Inhibitors]. Owada-Ozaki Y; Nishiyama K; Kobayashi T; Suzutani T; Suzuki H Gan To Kagaku Ryoho; 2018 Sep; 45(9):1234-1237. PubMed ID: 30237361 [TBL] [Abstract][Full Text] [Related]
32. Dysbiosis of the gut and lung microbiome has a role in asthma. Hufnagl K; Pali-Schöll I; Roth-Walter F; Jensen-Jarolim E Semin Immunopathol; 2020 Feb; 42(1):75-93. PubMed ID: 32072252 [TBL] [Abstract][Full Text] [Related]
33. Recent insights into the role of the microbiome in malignant and benign hematologic diseases. Fattizzo B; Cavallaro F; Folino F; Barcellini W Crit Rev Oncol Hematol; 2021 Apr; 160():103289. PubMed ID: 33667659 [TBL] [Abstract][Full Text] [Related]
34. The human microbiome in disease and pathology. Manos J APMIS; 2022 Dec; 130(12):690-705. PubMed ID: 35393656 [TBL] [Abstract][Full Text] [Related]
35. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Sun MF; Shen YQ Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121 [TBL] [Abstract][Full Text] [Related]
36. Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models. Pensec C; Gillaizeau F; Guenot D; Bessard A; Carton T; Leuillet S; Campone M; Neunlist M; Blottière HM; Le Vacon F Sci Rep; 2020 Jun; 10(1):9094. PubMed ID: 32499509 [TBL] [Abstract][Full Text] [Related]
37. [Oncological relevance of gut and urine microbiomes]. Oláh C; Váradi M; Horváth O; Nyirády P; Szarvas T Orv Hetil; 2021 Apr; 162(15):579-586. PubMed ID: 33798103 [TBL] [Abstract][Full Text] [Related]
38. Gut microbiome and cancer immunotherapy. Li W; Deng Y; Chu Q; Zhang P Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593 [TBL] [Abstract][Full Text] [Related]
39. Intestinal microbiota in liver disease. Haque TR; Barritt AS Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904 [TBL] [Abstract][Full Text] [Related]
40. Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors. Daillère R; Routy B; Goubet AG; Cogdill A; Ferrere G; Alves-Costa Silva C; Fluckiger A; Ly P; Haddad Y; Pizzato E; Thelemaque C; Fidelle M; Mazzenga M; Roberti MP; Melenotte C; Liu P; Terrisse S; Kepp O; Kroemer G; Zitvogel L; Derosa L Oncoimmunology; 2020 Jul; 9(1):1794423. PubMed ID: 32934888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]